RT-qPCR and ELISA showed that the levels of IL-4, IL-5, IL-6, IL-13 and TNF-α in PA-IL-32-AD-model treated with sh-JAK1 or miR-155 inhibitor were significantly decreased (Fig. 6B, C). Here, IL5 is linked to Alzheimer disease.